CDS

The submission describes a specialized bioinformatics software service, but provides nonsensical and exaggerated claims regarding traction and audience ('everyone', 'most people have used my product'). The use of 'marketcap' instead of monthly revenue suggests a crypto token rather than a traditional SaaS or consultancy, while providing zero verifiable metrics. The low score reflects unsupported claims, poor response quality, and lack of credible evidence of traction.